drugset / Trial / NCT00934167

Efficacy of Sodium Heparin for Prophylaxis of Venous Thromboembolism in Surgical Patients

NCT00934167

Phase 2/3 Unknown 140 enrolled Azidus Brasil
RandomizedParallel-groupOpen-labelPrevention

Summary

The aim of this study is to verify, through clinical examination and doppler, the non-inferiority of the drug test (heparin sodium 5.000UI/0.25 mL - HIPOLABOR) in relation to the drug compared (heparin sodium 5.000USP/mL - APP) in preventing the development of venous thromboembolism (VTE) in patients undergoing surgery for medium risk for the development of this pathology.

Timeline

Start
2010-05
Primary completion
2010-11
Completion
2011-09

Drugs

EvaluationDrugModalityDoseRoute
Comparator Heparin Other / unclassified 5000 iu
Comparator Heparin Other / unclassified 5000 unknown